Leveraging Trump’s impending tariffs, pharma companies have called on Europe again to change regulation, threatening a US ...

Pharma companies including Pfizer and MSD warn EU their €100bn investment plans could shift to the US over tariffs ...

Europe's pharma sector now trails the US, it went on to say, "on every investor metric from availability of capital, ...

Pharma companies are leveraging the United States’ threat of tariffs on drug imports to push for policy changes in the EU. | ...

President Trump unveiled a wide-ranging executive order that aims to lower drug prices, boost transparency into fees charged ...

Playing both sides of trade war, pharma companies are asking for certain compensations for scientific innovation and a ...

The United States is the biggest market by sales for big pharma companies, and Europe and the United States have ...

The EU abolished tariffs between its member states when the customs union was created in 1968. Goods imported to the EU from the rest of the world are subject to tariffs that follow the rules and ...

The EU executive and top pharmaceutical companies shared a video call to address concerns over potential US tariffs on drugs ...

New York: Pfizer Inc. has announced that the European Commission (EC) has issued a decision amending the marketing authorization for ABRYSVO, the company’s bivalent respiratory syncytial virus (RSV) ...

NEW YORK, NY, USA I April 01, 2025 I Pfizer Inc. (NYSE: PFE) announced today that the European Commission (EC) has issued a decision amending the marketing authorization for ABRYSVO ®, the company’s ...

Pfizer Inc. announced that the European Commission (EC) has issued a decision amending the marketing authorization for Abrysvo, the company’s bivalent respiratory syncytial virus (RSV) prefusion F ...